Cancer Gene Therapy http://www.nature.com/cgt/journal/vaop/ncurrent/rss.rdf Nature Publishing Group en Copyright © Nature Publishing Group Cancer Gene Therapy 0929-1903 Copyright © Nature Publishing Group permissions@nature.com Cancer Gene Therapy http://www.nature.com/aj/images/logos_b_o_w/cgt.gif http://www.nature.com/cgt/ An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors http://dx.doi.org/10.1038/cgt.2008.46 An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors

Cancer Gene Therapy advance online publication, August 1, 2008. doi:10.1038/cgt.2008.46

Authors: N Lei, F B Shen, J H Chang, L Wang, H Li, C Yang, J Li & D C Yu

]]> An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors N Lei F B Shen J H Chang L Wang H Li C Yang J Li D C Yu doi:10.1038/cgt.2008.46 Cancer Gene Therapy advance online publication, August 1, 2008 August 1, 2008 Cancer Gene Therapy August 1, 2008 aop current Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems http://dx.doi.org/10.1038/cgt.2008.50 Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems

Cancer Gene Therapy advance online publication, September 19, 2008. doi:10.1038/cgt.2008.50

Authors: C-M Cheng, P-Y Chu, K-H Chuang, S R Roffler, C-H Kao, W-L Tseng, J Shiea, W-D Chang, Y-C Su, B-M Chen, Y-M Wang & T-L Cheng

]]> Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems C-M Cheng P-Y Chu K-H Chuang S R Roffler C-H Kao W-L Tseng J Shiea W-D Chang Y-C Su B-M Chen Y-M Wang T-L Cheng doi:10.1038/cgt.2008.50 Cancer Gene Therapy advance online publication, September 19, 2008 September 19, 2008 Cancer Gene Therapy September 19, 2008 aop current Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50 kb DNA fragmentation http://dx.doi.org/10.1038/cgt.2008.54 Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50 kb DNA fragmentation

Cancer Gene Therapy advance online publication, July 25, 2008. doi:10.1038/cgt.2008.54

Authors: J Zhou, X-Q Zhang, F Ashoori, D J McConkey, M A Knowles, L Dong & W F Benedict

]]> Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50 kb DNA fragmentation J Zhou X-Q Zhang F Ashoori D J McConkey M A Knowles L Dong W F Benedict doi:10.1038/cgt.2008.54 Cancer Gene Therapy advance online publication, July 25, 2008 July 25, 2008 Cancer Gene Therapy July 25, 2008 aop current Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors http://dx.doi.org/10.1038/cgt.2008.55 Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors

Cancer Gene Therapy advance online publication, July 25, 2008. doi:10.1038/cgt.2008.55

Authors: Y Gao, P Whitaker-Dowling, J A Griffin, M A Barmada & I Bergman

]]> Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors Y Gao P Whitaker-Dowling J A Griffin M A Barmada I Bergman doi:10.1038/cgt.2008.55 Cancer Gene Therapy advance online publication, July 25, 2008 July 25, 2008 Cancer Gene Therapy July 25, 2008 aop current Chimeric form of tumor necrosis factor-α has enhanced surface expression and antitumor activity http://dx.doi.org/10.1038/cgt.2008.57 Chimeric form of tumor necrosis factor-α has enhanced surface expression and antitumor activity

Cancer Gene Therapy advance online publication, July 25, 2008. doi:10.1038/cgt.2008.57

Authors: R Rieger, D Whitacre, M J Cantwell, C Prussak & T J Kipps

]]> Chimeric form of tumor necrosis factor-α has enhanced surface expression and antitumor activity R Rieger D Whitacre M J Cantwell C Prussak T J Kipps doi:10.1038/cgt.2008.57 Cancer Gene Therapy advance online publication, July 25, 2008 July 25, 2008 Cancer Gene Therapy July 25, 2008 aop current REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer http://dx.doi.org/10.1038/cgt.2008.58 REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer

Cancer Gene Therapy advance online publication, July 25, 2008. doi:10.1038/cgt.2008.58

Authors: K Kawasaki, M Watanabe, M Sakaguchi, Y Ogasawara, K Ochiai, Y Nasu, H Doihara, Y Kashiwakura, N-h Huh, H Kumon & H Date

]]> REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer K Kawasaki M Watanabe M Sakaguchi Y Ogasawara K Ochiai Y Nasu H Doihara Y Kashiwakura N-h Huh H Kumon H Date doi:10.1038/cgt.2008.58 Cancer Gene Therapy advance online publication, July 25, 2008 July 25, 2008 Cancer Gene Therapy July 25, 2008 aop current Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter http://dx.doi.org/10.1038/cgt.2008.59 Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter

Cancer Gene Therapy advance online publication, September 5, 2008. doi:10.1038/cgt.2008.59

Authors: M Ahn, S-J Lee, X Li, J A Jiménez, Y-P Zhang, K-H Bae, Y Mohammadi, C Kao & T A Gardner

]]> Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter M Ahn S-J Lee X Li J A Jiménez Y-P Zhang K-H Bae Y Mohammadi C Kao T A Gardner doi:10.1038/cgt.2008.59 Cancer Gene Therapy advance online publication, September 5, 2008 September 5, 2008 Cancer Gene Therapy September 5, 2008 aop current Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response http://dx.doi.org/10.1038/cgt.2008.60 Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response

Cancer Gene Therapy advance online publication, August 8, 2008. doi:10.1038/cgt.2008.60

Authors: S Neves, H Faneca, S Bertin, K Konopka, N Düzgüneş, V Pierrefite-Carle, S Simões & M C Pedroso de Lima

]]> Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response S Neves H Faneca S Bertin K Konopka N Düzgüneş V Pierrefite-Carle S Simões M C Pedroso de Lima doi:10.1038/cgt.2008.60 Cancer Gene Therapy advance online publication, August 8, 2008 August 8, 2008 Cancer Gene Therapy August 8, 2008 aop current Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA http://dx.doi.org/10.1038/cgt.2008.61 Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA

Cancer Gene Therapy advance online publication, August 8, 2008. doi:10.1038/cgt.2008.61

Authors: J-N Zheng, D-S Pei, L-J Mao, X-Y Liu, D-D Mei, B-F Zhang, Z Shi, R-M Wen & X-Q Sun

]]> Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA J-N Zheng D-S Pei L-J Mao X-Y Liu D-D Mei B-F Zhang Z Shi R-M Wen X-Q Sun doi:10.1038/cgt.2008.61 Cancer Gene Therapy advance online publication, August 8, 2008 August 8, 2008 Cancer Gene Therapy August 8, 2008 aop current TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma http://dx.doi.org/10.1038/cgt.2008.62 TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma

Cancer Gene Therapy advance online publication, August 1, 2008. doi:10.1038/cgt.2008.62

Authors: M Enderlin, E V Kleinmann, S Struyf, C Buracchi, A Vecchi, R Kinscherf, F Kiessling, S Paschek, S Sozzani, J Rommelaere, J J Cornelis, J Van Damme & C Dinsart

]]> TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma M Enderlin E V Kleinmann S Struyf C Buracchi A Vecchi R Kinscherf F Kiessling S Paschek S Sozzani J Rommelaere J J Cornelis J Van Damme C Dinsart doi:10.1038/cgt.2008.62 Cancer Gene Therapy advance online publication, August 1, 2008 August 1, 2008 Cancer Gene Therapy August 1, 2008 aop current Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo http://dx.doi.org/10.1038/cgt.2008.63 Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo

Cancer Gene Therapy advance online publication, August 8, 2008. doi:10.1038/cgt.2008.63

Authors: M P Rubinstein, M L Salem, A N Kadima, C L Nguyen, W E Gillanders, M I Nishimura & D J Cole

]]> Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo M P Rubinstein M L Salem A N Kadima C L Nguyen W E Gillanders M I Nishimura D J Cole doi:10.1038/cgt.2008.63 Cancer Gene Therapy advance online publication, August 8, 2008 August 8, 2008 Cancer Gene Therapy August 8, 2008 aop current Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo http://dx.doi.org/10.1038/cgt.2008.64 Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo

Cancer Gene Therapy advance online publication, August 29, 2008. doi:10.1038/cgt.2008.64

Authors: M-S Song, J-S Jeong, G Ban, J-H Lee, Y-S Won, K-S Cho, I-H Kim & S-W Lee

]]> Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo M-S Song J-S Jeong G Ban J-H Lee Y-S Won K-S Cho I-H Kim S-W Lee doi:10.1038/cgt.2008.64 Cancer Gene Therapy advance online publication, August 29, 2008 August 29, 2008 Cancer Gene Therapy August 29, 2008 aop current Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer http://dx.doi.org/10.1038/cgt.2008.65 Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer

Cancer Gene Therapy advance online publication, September 5, 2008. doi:10.1038/cgt.2008.65

Authors: L P Lefter, S Dima, M Sunamura, T Furukawa, Y Sato, M Abe, M Chivu, I Popescu & A Horii

]]> Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer L P Lefter S Dima M Sunamura T Furukawa Y Sato M Abe M Chivu I Popescu A Horii doi:10.1038/cgt.2008.65 Cancer Gene Therapy advance online publication, September 5, 2008 September 5, 2008 Cancer Gene Therapy September 5, 2008 aop current E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer http://dx.doi.org/10.1038/cgt.2008.67 E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer

Cancer Gene Therapy advance online publication, September 26, 2008. doi:10.1038/cgt.2008.67

Authors: K Fukuda, M Abei, H Ugai, R Kawashima, E Seo, M Wakayama, T Murata, S Endo, H Hamada, I Hyodo & K K Yokoyama

]]> E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer K Fukuda M Abei H Ugai R Kawashima E Seo M Wakayama T Murata S Endo H Hamada I Hyodo K K Yokoyama doi:10.1038/cgt.2008.67 Cancer Gene Therapy advance online publication, September 26, 2008 September 26, 2008 Cancer Gene Therapy September 26, 2008 aop current Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV http://dx.doi.org/10.1038/cgt.2008.68 Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV

Cancer Gene Therapy advance online publication, August 29, 2008. doi:10.1038/cgt.2008.68

Authors: D T Ho, S Wykoff-Clary, C S Gross, D Schneider, F Jin, P J Kretschmer & T W Hermiston

]]> Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV D T Ho S Wykoff-Clary C S Gross D Schneider F Jin P J Kretschmer T W Hermiston doi:10.1038/cgt.2008.68 Cancer Gene Therapy advance online publication, August 29, 2008 August 29, 2008 Cancer Gene Therapy August 29, 2008 aop current Recent advances in p53 research: an interdisciplinary perspective http://dx.doi.org/10.1038/cgt.2008.69 Recent advances in p53 research: an interdisciplinary perspective

Cancer Gene Therapy advance online publication, September 19, 2008. doi:10.1038/cgt.2008.69

Authors: M Olivier, A Petitjean, V Marcel, A Pétré, M Mounawar, A Plymoth, C C de Fromentel & P Hainaut

]]> Recent advances in p53 research: an interdisciplinary perspective M Olivier A Petitjean V Marcel A Pétré M Mounawar A Plymoth C C de Fromentel P Hainaut doi:10.1038/cgt.2008.69 Cancer Gene Therapy advance online publication, September 19, 2008 September 19, 2008 Cancer Gene Therapy September 19, 2008 aop current PET imaging of heat-inducible suicide gene expression in mice bearing head and neck squamous cell carcinoma xenografts http://dx.doi.org/10.1038/cgt.2008.70 PET imaging of heat-inducible suicide gene expression in mice bearing head and neck squamous cell carcinoma xenografts

Cancer Gene Therapy advance online publication, August 29, 2008. doi:10.1038/cgt.2008.70

Authors: J J Parry, V Sharma, R Andrews, E G Moros, D Piwnica-Worms & B E Rogers

]]> PET imaging of heat-inducible suicide gene expression in mice bearing head and neck squamous cell carcinoma xenografts J J Parry V Sharma R Andrews E G Moros D Piwnica-Worms B E Rogers doi:10.1038/cgt.2008.70 Cancer Gene Therapy advance online publication, August 29, 2008 August 29, 2008 Cancer Gene Therapy August 29, 2008 aop current Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model http://dx.doi.org/10.1038/cgt.2008.71 Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model

Cancer Gene Therapy advance online publication, September 26, 2008. doi:10.1038/cgt.2008.71

Authors: F Kamlah, B G Eul, S Li, N Lang, L M Marsh, W Seeger, F Grimminger, F Rose & J Hänze

]]> Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model F Kamlah B G Eul S Li N Lang L M Marsh W Seeger F Grimminger F Rose J Hänze doi:10.1038/cgt.2008.71 Cancer Gene Therapy advance online publication, September 26, 2008 September 26, 2008 Cancer Gene Therapy September 26, 2008 aop current Exploiting the tumor microenvironment in the development of targeted cancer gene therapy http://dx.doi.org/10.1038/cgt.2008.72 Exploiting the tumor microenvironment in the development of targeted cancer gene therapy

Cancer Gene Therapy advance online publication, September 26, 2008. doi:10.1038/cgt.2008.72

Authors: G J Dougherty & S T Dougherty

]]> Exploiting the tumor microenvironment in the development of targeted cancer gene therapy G J Dougherty S T Dougherty doi:10.1038/cgt.2008.72 Cancer Gene Therapy advance online publication, September 26, 2008 September 26, 2008 Cancer Gene Therapy September 26, 2008 aop current Transcription factors: their potential as targets for an individualized therapeutic approach to cancer http://dx.doi.org/10.1038/cgt.2008.73 Transcription factors: their potential as targets for an individualized therapeutic approach to cancer

Cancer Gene Therapy advance online publication, October 10, 2008. doi:10.1038/cgt.2008.73

Authors: C Mees, J Nemunaitis & N Senzer

]]> Transcription factors: their potential as targets for an individualized therapeutic approach to cancer C Mees J Nemunaitis N Senzer doi:10.1038/cgt.2008.73 Cancer Gene Therapy advance online publication, October 10, 2008 October 10, 2008 Cancer Gene Therapy October 10, 2008 aop current Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells http://dx.doi.org/10.1038/cgt.2008.74 Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells

Cancer Gene Therapy advance online publication, October 10, 2008. doi:10.1038/cgt.2008.74

Authors: J Altomonte, L Wu, M Meseck, L Chen, O Ebert, A Garcia-Sastre, J Fallon, J Mandeli & S L C Woo

]]> Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells J Altomonte L Wu M Meseck L Chen O Ebert A Garcia-Sastre J Fallon J Mandeli S L C Woo doi:10.1038/cgt.2008.74 Cancer Gene Therapy advance online publication, October 10, 2008 October 10, 2008 Cancer Gene Therapy October 10, 2008 aop current Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity http://dx.doi.org/10.1038/cgt.2008.75 Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity

Cancer Gene Therapy advance online publication, October 17, 2008. doi:10.1038/cgt.2008.75

Authors: Y Piao, H Jiang, R Alemany, V Krasnykh, F C Marini, J Xu, M M Alonso, C A Conrad, K D Aldape, C Gomez-Manzano & J Fueyo

]]> Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity Y Piao H Jiang R Alemany V Krasnykh F C Marini J Xu M M Alonso C A Conrad K D Aldape C Gomez-Manzano J Fueyo doi:10.1038/cgt.2008.75 Cancer Gene Therapy advance online publication, October 17, 2008 October 17, 2008 Cancer Gene Therapy October 17, 2008 aop current Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation http://dx.doi.org/10.1038/cgt.2008.76 Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation

Cancer Gene Therapy advance online publication, October 10, 2008. doi:10.1038/cgt.2008.76

Authors: L R McNally, E L Rosenthal, W Zhang & D J Buchsbaum

]]> Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation L R McNally E L Rosenthal W Zhang D J Buchsbaum doi:10.1038/cgt.2008.76 Cancer Gene Therapy advance online publication, October 10, 2008 October 10, 2008 Cancer Gene Therapy October 10, 2008 aop current MicroRNA profile analysis of human prostate cancers http://dx.doi.org/10.1038/cgt.2008.77 MicroRNA profile analysis of human prostate cancers

Cancer Gene Therapy advance online publication, October 24, 2008. doi:10.1038/cgt.2008.77

Authors: A W Tong, P Fulgham, C Jay, P Chen, I Khalil, S Liu, N Senzer, A C Eklund, J Han & J Nemunaitis

]]> MicroRNA profile analysis of human prostate cancers A W Tong P Fulgham C Jay P Chen I Khalil S Liu N Senzer A C Eklund J Han J Nemunaitis doi:10.1038/cgt.2008.77 Cancer Gene Therapy advance online publication, October 24, 2008 October 24, 2008 Cancer Gene Therapy October 24, 2008 aop current Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth http://dx.doi.org/10.1038/cgt.2008.78 Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth

Cancer Gene Therapy advance online publication, October 24, 2008. doi:10.1038/cgt.2008.78

Authors: P Pu, Z Zhang, C Kang, R Jiang, Z Jia, G Wang & H Jiang

]]> Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth P Pu Z Zhang C Kang R Jiang Z Jia G Wang H Jiang doi:10.1038/cgt.2008.78 Cancer Gene Therapy advance online publication, October 24, 2008 October 24, 2008 Cancer Gene Therapy October 24, 2008 aop current Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA http://dx.doi.org/10.1038/cgt.2008.79 Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA

Cancer Gene Therapy advance online publication, October 17, 2008. doi:10.1038/cgt.2008.79

Authors: M Mikhaylova, I Stasinopoulos, Y Kato, D Artemov & Z M Bhujwalla

]]> Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA M Mikhaylova I Stasinopoulos Y Kato D Artemov Z M Bhujwalla doi:10.1038/cgt.2008.79 Cancer Gene Therapy advance online publication, October 17, 2008 October 17, 2008 Cancer Gene Therapy October 17, 2008 aop current Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats http://dx.doi.org/10.1038/cgt.2008.80 Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats

Cancer Gene Therapy advance online publication, November 14, 2008. doi:10.1038/cgt.2008.80

Authors: A M Sonabend, I V Ulasov, Y Han, C E Rolle, S Nandi, D Cao, M A Tyler & M S Lesniak

]]> Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats A M Sonabend I V Ulasov Y Han C E Rolle S Nandi D Cao M A Tyler M S Lesniak doi:10.1038/cgt.2008.80 Cancer Gene Therapy advance online publication, November 14, 2008 November 14, 2008 Cancer Gene Therapy November 14, 2008 aop current The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells http://dx.doi.org/10.1038/cgt.2008.81 The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells

Cancer Gene Therapy advance online publication, October 24, 2008. doi:10.1038/cgt.2008.81

Authors: T Katsura, S Iwai, Y Ota, H Shimizu, K Ikuta & Y Yura

]]> The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells T Katsura S Iwai Y Ota H Shimizu K Ikuta Y Yura doi:10.1038/cgt.2008.81 Cancer Gene Therapy advance online publication, October 24, 2008 October 24, 2008 Cancer Gene Therapy October 24, 2008 aop current Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo http://dx.doi.org/10.1038/cgt.2008.82 Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo

Cancer Gene Therapy advance online publication, October 24, 2008. doi:10.1038/cgt.2008.82

Authors: X H Shi, Z Y Liang, X Y Ren & T H Liu

]]> Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo X H Shi Z Y Liang X Y Ren T H Liu doi:10.1038/cgt.2008.82 Cancer Gene Therapy advance online publication, October 24, 2008 October 24, 2008 Cancer Gene Therapy October 24, 2008 aop current Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice http://dx.doi.org/10.1038/cgt.2008.83 Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice

Cancer Gene Therapy advance online publication, November 7, 2008. doi:10.1038/cgt.2008.83

Authors: Y Kulu, J D Dorfman, D Kuruppu, B C Fuchs, J M Goodwin, T Fujii, T Kuroda, M Lanuti & K K Tanabe

]]> Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice Y Kulu J D Dorfman D Kuruppu B C Fuchs J M Goodwin T Fujii T Kuroda M Lanuti K K Tanabe doi:10.1038/cgt.2008.83 Cancer Gene Therapy advance online publication, November 7, 2008 November 7, 2008 Cancer Gene Therapy November 7, 2008 aop current Reovirus infection of cancer cells is not due to activated Ras pathway http://dx.doi.org/10.1038/cgt.2008.84 Reovirus infection of cancer cells is not due to activated Ras pathway

Cancer Gene Therapy advance online publication, October 24, 2008. doi:10.1038/cgt.2008.84

Authors: L Song, T Ohnuma, I H Gelman & J F Holland

]]> Reovirus infection of cancer cells is not due to activated Ras pathway L Song T Ohnuma I H Gelman J F Holland doi:10.1038/cgt.2008.84 Cancer Gene Therapy advance online publication, October 24, 2008 October 24, 2008 Cancer Gene Therapy October 24, 2008 aop current Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy http://dx.doi.org/10.1038/cgt.2008.85 Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy

Cancer Gene Therapy advance online publication, October 24, 2008. doi:10.1038/cgt.2008.85

Authors: C Tosch, M Geist, C Ledoux, C Ziller-Remi, S Paul, P Erbs, N Corvaia, P Von Hoegen, J-M Balloul & H Haegel

]]> Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy C Tosch M Geist C Ledoux C Ziller-Remi S Paul P Erbs N Corvaia P Von Hoegen J-M Balloul H Haegel doi:10.1038/cgt.2008.85 Cancer Gene Therapy advance online publication, October 24, 2008 October 24, 2008 Cancer Gene Therapy October 24, 2008 aop current Translational strategies exploiting TNF-α that sensitize tumors to radiation therapy http://dx.doi.org/10.1038/cgt.2008.86 Translational strategies exploiting TNF-α that sensitize tumors to radiation therapy

Cancer Gene Therapy advance online publication, October 31, 2008. doi:10.1038/cgt.2008.86

Authors: H J Mauceri, M A Beckett, H Liang, H G Sutton, S Pitroda, E Galka, E Efimova, T Darga, N N Khodarev, C R King, M C Posner, S Hellman, D W Kufe & R R Weichselbaum

]]> Translational strategies exploiting TNF-α that sensitize tumors to radiation therapy H J Mauceri M A Beckett H Liang H G Sutton S Pitroda E Galka E Efimova T Darga N N Khodarev C R King M C Posner S Hellman D W Kufe R R Weichselbaum doi:10.1038/cgt.2008.86 Cancer Gene Therapy advance online publication, October 31, 2008 October 31, 2008 Cancer Gene Therapy October 31, 2008 aop current Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent http://dx.doi.org/10.1038/cgt.2008.87 Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent

Cancer Gene Therapy advance online publication, October 24, 2008. doi:10.1038/cgt.2008.87

Authors: I Gentschev, J Stritzker, E Hofmann, S Weibel, Y A Yu, N Chen, Q Zhang, J Bullerdiek, I Nolte & A A Szalay

]]> Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent I Gentschev J Stritzker E Hofmann S Weibel Y A Yu N Chen Q Zhang J Bullerdiek I Nolte A A Szalay doi:10.1038/cgt.2008.87 Cancer Gene Therapy advance online publication, October 24, 2008 October 24, 2008 Cancer Gene Therapy October 24, 2008 aop current Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma http://dx.doi.org/10.1038/cgt.2008.88 Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma

Cancer Gene Therapy advance online publication, November 7, 2008. doi:10.1038/cgt.2008.88

Authors: B Lortal, F Gross, J M Peron, M Pénary, D Berg, I Hennebelle, G Favre & B Couderc

]]> Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma B Lortal F Gross J M Peron M Pénary D Berg I Hennebelle G Favre B Couderc doi:10.1038/cgt.2008.88 Cancer Gene Therapy advance online publication, November 7, 2008 November 7, 2008 Cancer Gene Therapy November 7, 2008 aop current High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome http://dx.doi.org/10.1038/cgt.2008.89 High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome

Cancer Gene Therapy advance online publication, November 7, 2008. doi:10.1038/cgt.2008.89

Authors: N Grinshtein, M Ventresca, R Margl, D Bernard, T-C Yang, J B Millar, J Hummel, F Beermann, Y Wan & J L Bramson

]]> High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome N Grinshtein M Ventresca R Margl D Bernard T-C Yang J B Millar J Hummel F Beermann Y Wan J L Bramson doi:10.1038/cgt.2008.89 Cancer Gene Therapy advance online publication, November 7, 2008 November 7, 2008 Cancer Gene Therapy November 7, 2008 aop current Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer http://dx.doi.org/10.1038/cgt.2008.90 Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer

Cancer Gene Therapy advance online publication, November 14, 2008. doi:10.1038/cgt.2008.90

Authors: S Ganesh, M Gonzalez-Edick, D Gibbons, Y Ge, M VanRoey, M Robinson & K Jooss

]]> Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer S Ganesh M Gonzalez-Edick D Gibbons Y Ge M VanRoey M Robinson K Jooss doi:10.1038/cgt.2008.90 Cancer Gene Therapy advance online publication, November 14, 2008 November 14, 2008 Cancer Gene Therapy November 14, 2008 aop current An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models http://dx.doi.org/10.1038/cgt.2008.91 An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models

Cancer Gene Therapy advance online publication, November 7, 2008. doi:10.1038/cgt.2008.91

Authors: S Dharmapuri, L Aurisicchio, P Neuner, M Verdirame, G Ciliberto & N La Monica

]]> An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models S Dharmapuri L Aurisicchio P Neuner M Verdirame G Ciliberto N La Monica doi:10.1038/cgt.2008.91 Cancer Gene Therapy advance online publication, November 7, 2008 November 7, 2008 Cancer Gene Therapy November 7, 2008 aop current PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types http://dx.doi.org/10.1038/cgt.2008.92 PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types

Cancer Gene Therapy advance online publication, November 7, 2008. doi:10.1038/cgt.2008.92

Authors: A Mishra, A K Ormerod, M L Cibull, B T Spear, S D Kraner & D M Kaetzel

]]> PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types A Mishra A K Ormerod M L Cibull B T Spear S D Kraner D M Kaetzel doi:10.1038/cgt.2008.92 Cancer Gene Therapy advance online publication, November 7, 2008 November 7, 2008 Cancer Gene Therapy November 7, 2008 aop current Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer http://dx.doi.org/10.1038/cgt.2008.93 Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer

Cancer Gene Therapy advance online publication, November 14, 2008. doi:10.1038/cgt.2008.93

Authors: H Lu, C-S Chen & D J Waxman

]]> Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer H Lu C-S Chen D J Waxman doi:10.1038/cgt.2008.93 Cancer Gene Therapy advance online publication, November 14, 2008 November 14, 2008 Cancer Gene Therapy November 14, 2008 aop current